292 related articles for article (PubMed ID: 26100672)
1. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
Russell MR; Penikis A; Oldridge DA; Alvarez-Dominguez JR; McDaniel L; Diamond M; Padovan O; Raman P; Li Y; Wei JS; Zhang S; Gnanchandran J; Seeger R; Asgharzadeh S; Khan J; Diskin SJ; Maris JM; Cole KA
Cancer Res; 2015 Aug; 75(15):3155-66. PubMed ID: 26100672
[TBL] [Abstract][Full Text] [Related]
2. Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis.
Mondal T; Juvvuna PK; Kirkeby A; Mitra S; Kosalai ST; Traxler L; Hertwig F; Wernig-Zorc S; Miranda C; Deland L; Volland R; Bartenhagen C; Bartsch D; Bandaru S; Engesser A; Subhash S; Martinsson T; Carén H; Akyürek LM; Kurian L; Kanduri M; Huarte M; Kogner P; Fischer M; Kanduri C
Cancer Cell; 2018 Mar; 33(3):417-434.e7. PubMed ID: 29533783
[TBL] [Abstract][Full Text] [Related]
3. The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching.
Lessard L; Liu M; Marzese DM; Wang H; Chong K; Kawas N; Donovan NC; Kiyohara E; Hsu S; Nelson N; Izraely S; Sagi-Assif O; Witz IP; Ma XJ; Luo Y; Hoon DSB
J Invest Dermatol; 2015 Oct; 135(10):2464-2474. PubMed ID: 26016895
[TBL] [Abstract][Full Text] [Related]
4. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.
Pandey GK; Mitra S; Subhash S; Hertwig F; Kanduri M; Mishra K; Fransson S; Ganeshram A; Mondal T; Bandaru S; Ostensson M; Akyürek LM; Abrahamsson J; Pfeifer S; Larsson E; Shi L; Peng Z; Fischer M; Martinsson T; Hedborg F; Kogner P; Kanduri C
Cancer Cell; 2014 Nov; 26(5):722-37. PubMed ID: 25517750
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma.
Maris JM; Mosse YP; Bradfield JP; Hou C; Monni S; Scott RH; Asgharzadeh S; Attiyeh EF; Diskin SJ; Laudenslager M; Winter C; Cole KA; Glessner JT; Kim C; Frackelton EC; Casalunovo T; Eckert AW; Capasso M; Rappaport EF; McConville C; London WB; Seeger RC; Rahman N; Devoto M; Grant SF; Li H; Hakonarson H
N Engl J Med; 2008 Jun; 358(24):2585-93. PubMed ID: 18463370
[TBL] [Abstract][Full Text] [Related]
6. NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma.
Juvvuna PK; Mondal T; Di Marco M; Kosalai ST; Kanduri M; Kanduri C
Neurooncol Adv; 2021; 3(1):vdab056. PubMed ID: 34056606
[TBL] [Abstract][Full Text] [Related]
7. The dual functions of the long noncoding RNA CASC15 in malignancy.
Gu X; Chu Q; Zheng Q; Wang J; Zhu H
Biomed Pharmacother; 2021 Mar; 135():111212. PubMed ID: 33433353
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs and neuroblastoma.
Pandey GK; Kanduri C
Oncotarget; 2015 Jul; 6(21):18265-75. PubMed ID: 26087192
[TBL] [Abstract][Full Text] [Related]
9. Role of long noncoding RNA in neuroblastoma.
Ye M; Liu B; Zhang J; Dong K
Discov Med; 2020; 30(160):71-82. PubMed ID: 33382963
[TBL] [Abstract][Full Text] [Related]
10. High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma.
Barnhill LM; Williams RT; Cohen O; Kim Y; Batova A; Mielke JA; Messer K; Pu M; Bao L; Yu AL; Diccianni MB
Cancer Res; 2014 Jul; 74(14):3753-63. PubMed ID: 25028366
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population.
He J; Zhang R; Zou Y; Zhu J; Yang T; Wang F; Xia H
Tumour Biol; 2016 Feb; 37(2):1635-9. PubMed ID: 26307394
[TBL] [Abstract][Full Text] [Related]
12.
Zhang J; Zhuo ZJ; Wang J; He J; Yang L; Zhang D; Qin P; Yan L
Oncotarget; 2017 Oct; 8(53):91343-91349. PubMed ID: 29207648
[TBL] [Abstract][Full Text] [Related]
13. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
[TBL] [Abstract][Full Text] [Related]
14. CASC15: A Tumor-Associated Long Non-Coding RNA.
Wang B; Xu W; Cai Y; Guo C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(1):127-134. PubMed ID: 32962611
[TBL] [Abstract][Full Text] [Related]
15. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor.
Cimmino F; Avitabile M; Diskin SJ; Vaksman Z; Pignataro P; Formicola D; Cardinale A; Testori A; Koster J; de Torres C; Devoto M; Maris JM; Iolascon A; Capasso M
Int J Cancer; 2018 Dec; 143(11):2828-2837. PubMed ID: 30132831
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM
Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269
[TBL] [Abstract][Full Text] [Related]
17. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
18. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
[TBL] [Abstract][Full Text] [Related]
19. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
20. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Capasso M; Devoto M; Hou C; Asgharzadeh S; Glessner JT; Attiyeh EF; Mosse YP; Kim C; Diskin SJ; Cole KA; Bosse K; Diamond M; Laudenslager M; Winter C; Bradfield JP; Scott RH; Jagannathan J; Garris M; McConville C; London WB; Seeger RC; Grant SF; Li H; Rahman N; Rappaport E; Hakonarson H; Maris JM
Nat Genet; 2009 Jun; 41(6):718-23. PubMed ID: 19412175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
